313 related articles for article (PubMed ID: 27835605)
21. Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA.
Zhang YJ; Wu HC; Shen J; Ahsan H; Tsai WY; Yang HI; Wang LY; Chen SY; Chen CJ; Santella RM
Clin Cancer Res; 2007 Apr; 13(8):2378-84. PubMed ID: 17438096
[TBL] [Abstract][Full Text] [Related]
22. Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach.
Gentilini D; Scala S; Gaudenzi G; Garagnani P; Capri M; Cescon M; Grazi GL; Bacalini MG; Pisoni S; Dicitore A; Circelli L; Santagata S; Izzo F; Di Blasio AM; Persani L; Franceschi C; Vitale G
Oncotarget; 2017 Jun; 8(26):41890-41902. PubMed ID: 28514750
[TBL] [Abstract][Full Text] [Related]
23. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.
Ko E; Kim Y; Kim SJ; Joh JW; Song S; Park CK; Park J; Kim DH
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2260-7. PubMed ID: 18723830
[TBL] [Abstract][Full Text] [Related]
24. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
Zhang C; Li Z; Cheng Y; Jia F; Li R; Wu M; Li K; Wei L
Clin Cancer Res; 2007 Feb; 13(3):944-52. PubMed ID: 17289889
[TBL] [Abstract][Full Text] [Related]
25.
Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Buurman R; Skawran B; Lehmann U
World J Gastroenterol; 2017 Mar; 23(9):1568-1575. PubMed ID: 28321157
[TBL] [Abstract][Full Text] [Related]
26. Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma.
Nomoto S; Kinoshita T; Kato K; Otani S; Kasuya H; Takeda S; Kanazumi N; Sugimoto H; Nakao A
Br J Cancer; 2007 Nov; 97(9):1260-5. PubMed ID: 17968429
[TBL] [Abstract][Full Text] [Related]
27. Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liver.
Harder J; Opitz OG; Brabender J; Olschewski M; Blum HE; Nomoto S; Usadel H
Int J Cancer; 2008 Jun; 122(12):2800-4. PubMed ID: 18351580
[TBL] [Abstract][Full Text] [Related]
28. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.
Yang B; Guo M; Herman JG; Clark DP
Am J Pathol; 2003 Sep; 163(3):1101-7. PubMed ID: 12937151
[TBL] [Abstract][Full Text] [Related]
29. Quantitative analysis of multiple methylated genes in plasma for the diagnosis and prognosis of hepatocellular carcinoma.
Huang ZH; Hu Y; Hua D; Wu YY; Song MX; Cheng ZH
Exp Mol Pathol; 2011 Dec; 91(3):702-7. PubMed ID: 21884695
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide DNA methylation analysis in hepatocellular carcinoma.
Yamada N; Yasui K; Dohi O; Gen Y; Tomie A; Kitaichi T; Iwai N; Mitsuyoshi H; Sumida Y; Moriguchi M; Yamaguchi K; Nishikawa T; Umemura A; Naito Y; Tanaka S; Arii S; Itoh Y
Oncol Rep; 2016 Apr; 35(4):2228-36. PubMed ID: 26883180
[TBL] [Abstract][Full Text] [Related]
31. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
Sang L; Wang XM; Xu DY; Zhao WJ
World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
[TBL] [Abstract][Full Text] [Related]
32. Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma.
Nishida N; Kudo M; Nagasaka T; Ikai I; Goel A
Hepatology; 2012 Sep; 56(3):994-1003. PubMed ID: 22407776
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance and association of GSTP1 hypermethylation with hepatocellular carcinoma: A meta-analysis.
Li Y; Cai Y; Chen H; Mao L
J Cancer Res Ther; 2018 Jun; 14(Supplement):S486-S489. PubMed ID: 29970711
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological significance of RUNX3 gene hypermethylation in hepatocellular carcinoma.
Yang Y; Ye Z; Zou Z; Xiao G; Luo G; Yang H
Tumour Biol; 2014 Oct; 35(10):10333-40. PubMed ID: 25037468
[TBL] [Abstract][Full Text] [Related]
35. A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma.
Hu F; Miao L; Zhao Y; Xiao YY; Xu Q
Drug Des Devel Ther; 2015; 9():3625-33. PubMed ID: 26203228
[TBL] [Abstract][Full Text] [Related]
36. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma.
Su PF; Lee TC; Lin PJ; Lee PH; Jeng YM; Chen CH; Liang JD; Chiou LL; Huang GT; Lee HS
Int J Cancer; 2007 Sep; 121(6):1257-64. PubMed ID: 17534893
[TBL] [Abstract][Full Text] [Related]
37. Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas.
Gao W; Kondo Y; Shen L; Shimizu Y; Sano T; Yamao K; Natsume A; Goto Y; Ito M; Murakami H; Osada H; Zhang J; Issa JP; Sekido Y
Carcinogenesis; 2008 Oct; 29(10):1901-10. PubMed ID: 18632756
[TBL] [Abstract][Full Text] [Related]
38. Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker.
Anwar SL; Albat C; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Lehmann U
Int J Cancer; 2013 Aug; 133(3):660-70. PubMed ID: 23364900
[TBL] [Abstract][Full Text] [Related]
39. Methylation of multiple genes in hepatitis C virus associated hepatocellular carcinoma.
Zekri AR; Bahnasy AA; Shoeab FE; Mohamed WS; El-Dahshan DH; Ali FT; Sabry GM; Dasgupta N; Daoud SS
J Adv Res; 2014 Jan; 5(1):27-40. PubMed ID: 25685469
[TBL] [Abstract][Full Text] [Related]
40. Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake.
Lambert MP; Paliwal A; Vaissière T; Chemin I; Zoulim F; Tommasino M; Hainaut P; Sylla B; Scoazec JY; Tost J; Herceg Z
J Hepatol; 2011 Apr; 54(4):705-15. PubMed ID: 21146512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
